An unprecedented lineup of genome-edited cells including reporter cell lines and cells with disease-associated SNP, which are difficult to produce with conventional technologies, are available. Collaboration-friendly with a simple license.

Affordable genome service using Bayspair's Scarless Editing technology, which dramatically reduces the difficulty and cost of genome editing. We undertake genome editing of any design with a high success rate and on a contingency fee basis.

Bayspair's genome editing technology can be licensed for all purposes, including commercial and clinical applications, providing partners and collaborators with a flexible business scheme.